Director & President and CEO
Director & President and CEO at Atara Biotherapeutics, Inc., filing insider transactions between 2025-05-16 and 2026-05-18.
| SEC ↗ |
| 2026-03-02 | ATRA | Sale | 1,442 | $5.09 | $7K | SEC ↗ |
| 2026-03-02 | ATRA | Sale | 198 | $5.08 | $1K | SEC ↗ |
| 2025-11-17 | ATRA | Sale | 56 | $13.19 | $739 | SEC ↗ |
| 2025-11-17 | ATRA | Sale | 2,859 | $13.19 | $38K | SEC ↗ |
| 2025-08-18 | ATRA | Sale | 57 | $11.61 | $662 | SEC ↗ |
| 2025-08-18 | ATRA | Sale | 1,281 | $11.62 | $15K | SEC ↗ |
| 2025-08-18 | ATRA | Sale | 1,620 | $11.62 | $19K | SEC ↗ |
| 2025-05-16 | ATRA | Sale | 3,276 | $6.76 | $22K | SEC ↗ |